Fig. 1 · Structure
Documents & Downloads
Bupicomide
Dopamine Beta-monooxygenase Inhibitor
Bupicomide is a selective inhibitor of dopamine beta-monooxygenase, functioning through the mechanism analogous to fusaric acid. This compound has demonstrated utility in the study of hypertension, making it a valuable tool for research on neurochemical pathways related to blood pressure regulation and cardiovascular health.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 22632-06-0 |
| Applications | Dopamine Beta-monooxygenase Inhibitor |
| Formula | C10H14N2O |
| Molecular Weight | 178.23 |
| SMILES | O=C(N)C1=NC=C(C=C1)CCCC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.